Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
Advanced Accelerator Applications
Taproot Health
Hutchmed
Brahms AG
Ipsen
Novartis
Amgen
Novartis
Novartis
Eli Lilly and Company
Novartis
Arbutus Biopharma Corporation
Mateon Therapeutics
Novartis
Novartis
Novartis
Novartis
Molecular Insight Pharmaceuticals, Inc.
Cylene Pharmaceuticals
CASI Pharmaceuticals, Inc.
Callisto Pharmaceuticals